FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/04/066405 [Registered on: 26/04/2024] Trial Registered Prospectively
Last Modified On: 10/04/2024
Post Graduate Thesis  Yes 
Type of Trial  Observational 
Type of Study   PROSPECTIVE 
Study Design  Other 
Public Title of Study   A Study of adverse drug reactions in female subjects using oral contraceptive pills. 
Scientific Title of Study   A Prospective observational study for estimation of the adverse drug reactions in female subjects using oral contraceptive pills.  
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Aishwarya Dhakne 
Designation  JR1 MD Pharmacology 
Affiliation  Bharati Vidyapeeth deemed to be university medical college, Pune 
Address  Bharati vidyapeeth Deemed to be University Medical college, Pune Obstetrics and gynaecology department ground floor OPD in Bharati hospital, Pune, Maharashtra 411043

Pune
MAHARASHTRA
411043
India 
Phone  8698554023  
Fax    
Email  aishwarya.dhakne-mcp@bharatividyapeeth.edu  
 
Details of Contact Person
Scientific Query
 
Name  Dr Bhagyashri Rajopadhye 
Designation  Associate Professor Pharmacology Department 
Affiliation  Bharati Vidyapeeth deemed to be university medical college, Pune 
Address  Bharati vidyapeeth Deemed to be university Medical College Department of Pharmacology 1st floor,Pune, Maharashtra 411043.

Pune
MAHARASHTRA
411043
India 
Phone  9922451264  
Fax    
Email  bhagyashree.rajopadhye@bharatividyapeeth.edu  
 
Details of Contact Person
Public Query
 
Name  Dr Bhagyashri Rajopadhye 
Designation  Associate Professor Pharmacology Department 
Affiliation  Bharati Vidyapeeth deemed to be university medical college, Pune 
Address  Bharati Vidyapeeth deemed to be university medical college Department of Pharmacology, 1st floor, Pune.

Pune
MAHARASHTRA
411043
India 
Phone  9922451264  
Fax    
Email  bhagyashree.rajopadhye@bharatividyapeeth.edu  
 
Source of Monetary or Material Support  
Bharati Vidyapeeth Deemed to be university Hospital,Pune Maharashtra India, 411043 
 
Primary Sponsor  
Name  NA 
Address  NA 
Type of Sponsor  Private medical college 
 
Details of Secondary Sponsor  
Name  Address 
NA   
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 2  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Aishwarya Dhakne  Bharati Hospital, Pune Maharashtra, 411043  Obstetrics and gynaecology department, ground floor OPD.
Pune
MAHARASHTRA 
8698554023

aishwarya.dhakne-mcp@bharatividyapeeth.edu 
Dr Aishwarya Dhakne  Obstetrics and gynaecology department  Bharati vidyapeeth deemed to be university Hospital, Pune
Pune
MAHARASHTRA 
8698554023

aishwarya.dhakne-mcp@bharatividyapeeth.edu 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Bharati Vidyapeeth deemed to be University Medical college, Pune Institutional Ethics committee DCGI ECR 518  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: N948||Other specified conditions associated with female genital organs and menstrual cycle,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  NIL  NIL 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Female 
Details  1]Women of the age group 18-60 years freshly
prescribed OC pills
2]Women using OC pills for at least 1 month
3]Women who can recall ADR events
 
 
ExclusionCriteria 
Details  Women with chronic diseases like Hypertension, DM, Kidney disease and Liver disease 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
To evaluate the ADRs related to use of OC pills in three months duration  three months duration 
 
Secondary Outcome  
Outcome  TimePoints 
To estimate the proportion of female subjects using OC pills for contraceptive and non- contraceptive purpose.
To determine the perception of female subjects about OC pills
 
1 YEAR 
 
Target Sample Size   Total Sample Size="193"
Sample Size from India="193" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   08/05/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   This study is planned to understand the prescribing pattern of oral contraceptive pills and their side effects in a tertiary care hospital and its aim is to estimate the adverse drug reactions in female subjects using oral contraceptive pills. Our research question is what is the percentage of Adverse drug reactions in female subjects consuming OC pills in the duration of three months. Through this study we also want to know oral contraceptive pills non contraceptive uses  in polycystic ovarian disease , menstrual disorders , hormone replacement therapy etc. It is a prospective observational study carried out during one year. Patient follow up is done for adverse drug reactions for minimum 3 months. 
Close